Wnt signaling: Role in LTP, neural networks and memory

Ageing Research Reviews

Volumn 12, Issue 3, 2013, Pages 786-800

  Oliva, Carolina A ^a   Vargas, Jessica Y ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Basal spontaneous activity; LTP; Mental disorders; Neurodegenerative diseases; Wnt signaling

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; LITHIUM; WNT PROTEIN; WNT5A PROTEIN; WNT7A PROTEIN;

ALZHEIMER DISEASE; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; COGNITION; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; LONG TERM POTENTIATION; MEMORY; MENTAL DISEASE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERINATAL PERIOD; PRESYNAPTIC NERVE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEIZURE; WNT SIGNALING PATHWAY; DEGENERATIVE DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMANS; LONG-TERM POTENTIATION; MEMORY; MENTAL DISORDERS; NERVE NET; NEURODEGENERATIVE DISEASES; WNT SIGNALING PATHWAY;

EID: 84892522551     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.03.006     Document Type: Review

References (204)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO Journal 1997, 16:3797-3804.
2. Abramov E., Dolev I., Fogel H., Ciccotosto G.D., Ruff E., Slutsky I. Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nature Neuroscience 2009, 12:1567-1576.
3. Adler P.N. Planar signaling and morphogenesis in Drosophila. Developmental Cell 2002, 2:525-535.
4. Ahmad-Annuar A., Ciani L., Simeonidis I., Herreros J., Fredj N.B., Rosso S.B., Hall A., Brickley S., Salinas P.C. Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. Journal of Cell Biology 2006, 174:127-139.
5. Ahnaou A., Drinkenburg W.H. Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice. Behavioural Brain Research 2011, 221:246-252.
6. Alimohamad H., Rajakumar N., Seah Y.H., Rushlow W. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biological Psychiatry 2005, 57:533-542.
7. Alimohamad H., Sutton L., Mouyal J., Rajakumar N., Rushlow W.J. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. Journal of Neurochemistry 2005, 95:513-525.
8. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., Inestrosa N.C. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Experimental Cell Research 2004, 297:186-196.
9. Alvarez G., Munoz-Montano J.R., Satrustegui J., Avila J., Bogonez E., Diaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Letters 1999, 453:260-264.
10. Amatniek J.C., Hauser W.A., DelCastillo-Castaneda C., Jacobs D.M., Marder K., Bell K., Albert M., Brandt J., Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006, 47:867-872.
11. Arrazola M.S., Varela-Nallar L., Colombres M., Toledo E.M., Cruzat F., Pavez L., Assar R., Aravena A., Gonzalez M., Montecino M., et al. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. Journal of Cellular Physiology 2009, 221:658-667.
12. Ataman B., Ashley J., Gorczyca M., Ramachandran P., Fouquet W., Sigrist S.J., Budnik V. Rapid activity-dependent modifications in synaptic structure and function require bidirectional Wnt signaling. Neuron 2008, 57:705-718.
13. Avila M.E., Sepulveda F.J., Burgos C.F., Moraga-Cid G., Parodi J., Moon R.T., Aguayo L.G., Opazo C., De Ferrari G.V. Canonical Wnt3a modulates intracellular calcium and enhances excitatory neurotransmission in hippocampal neurons. Journal of Biological Chemistry 2010, 285:18939-18947.
14. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annual Review of Pharmacology and Toxicology 2009, 49:327-347.
15. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
16. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:5099-5104.
17. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:1333-1338.
18. Beaumont V., Thompson S.A., Choudhry F., Nuthall H., Glantschnig H., Lipfert L., David G.R., Swain C.J., McAllister G., Munoz-Sanjuan I. Evidence for an enhancement of excitatory transmission in adult CNS by Wnt signaling pathway modulation. Molecular and Cellular Neurosciences 2007, 35:513-524.
19. Ben-Ari Y., Cherubini E., Corradetti R., Gaiarsa J.L. Giant synaptic potentials in immature rat CA3 hippocampal neurones. Journal of Physiology 1989, 416:303-325.
20. Bhanot P., Brink M., Samos C.H., Hsieh J.C., Wang Y., Macke J.P., Andrew D., Nathans J., Nusse R. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996, 382:225-230.
21. Bilic J., Huang Y.L., Davidson G., Zimmermann T., Cruciat C.M., Bienz M., Niehrs C. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007, 316:1619-1622.
22. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2173-2178.
23. Bosch M., Hayashi Y. Structural plasticity of dendritic spines. Current Opinion in Neurobiology 2012, 22:383-388.
24. Boutros M., Paricio N., Strutt D.I., Mlodzik M. Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 1998, 94:109-118.
25. Budnik V., Salinas P.C. Wnt signaling during synaptic development and plasticity. Current Opinion in Neurobiology 2011, 21:151-159.
26. Busceti C.L., Biagioni F., Aronica E., Riozzi B., Storto M., Battaglia G., Giorgi F.S., Gradini R., Fornai F., Caricasole A., et al. Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia 2007, 48:694-705.
27. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14:879-888.
28. Buzsaki G. Theta oscillations in the hippocampus. Neuron 2002, 33:325-340.
29. Cadigan K.M., Liu Y.I. Wnt signaling: complexity at the surface. Journal of Cell Science 2006, 119:395-402.
30. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes & Development 1997, 11:3286-3305.
31. Cappuccio I., Calderone A., Busceti C.L., Biagioni F., Pontarelli F., Bruno V., Storto M., Terstappen G.T., Gaviraghi G., Fornai F., et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. Journal of Neuroscience 2005, 25:2647-2657.
32. Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A.J., Caruso A., Storto M., Gaviraghi G., Terstappen G.C., Nicoletti F. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. Journal of Neuroscience 2004, 24:6021-6027.
33. Caroni P., Donato F., Muller D. Structural plasticity upon learning: regulation and functions. Nature Reviews Neuroscience 2012, 13:478-490.
34. Cerpa W., Farias G.G., Godoy J.A., Fuenzalida M., Bonansco C., Inestrosa N.C. Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Molecular Neurodegeneration 2010, 5:3.
35. Cerpa W., Gambrill A., Inestrosa N.C., Barria A. Regulation of NMDA-receptor synaptic transmission by Wnt signaling. Journal of Neuroscience 2011, 31:9466-9471.
36. Cerpa W., Godoy J.A., Alfaro I., Farias G.G., Metcalfe M.J., Fuentealba R., Bonansco C., Inestrosa N.C. Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. Journal of Biological Chemistry 2008, 283:5918-5927.
37. Chacon M.A., Varela-Nallar L., Inestrosa N.C. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers. Journal of Cellular Physiology 2008, 217:215-227.
38. Chen J., Park C.S., Tang S.J. Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. Journal of Biological Chemistry 2006, 281:11910-11916.
39. Chen M.J., Russo-Neustadt A.A. Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Research Molecular Brain Research 2005, 135:181-193.
40. Ciani L., Boyle K.A., Dickins E., Sahores M., Anane D., Lopes D.M., Gibb A.J., Salinas P.C. Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:10732-10737.
41. Ciani L., Salinas P.C. WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nature Reviews Neuroscience 2005, 6:351-362.
42. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature Neuroscience 2005, 8:79-84.
43. Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205.
44. Cliffe A., Hamada F., Bienz M. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Current Biology 2003, 13:960-966.
45. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
46. Cuitino L., Godoy J.A., Farias G.G., Couve A., Bonansco C., Fuenzalida M., Inestrosa N.C. Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. Journal of Neuroscience 2010, 30:8411-8420.
47. Cummings D.M., Andre V.M., Uzgil B.O., Gee S.M., Fisher Y.E., Cepeda C., Levine M.S. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. Journal of Neuroscience 2009, 29:10371-10386.
48. Cummings D.M., Cepeda C., Levine M.S. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. ASN Neuro 2010, 2:e00036.
49. Davis E.K., Zou Y., Ghosh A. Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation. Neural Development 2008, 3:32.
50. De Ferrari G.V., Chacon M.A., Barria M.I., Garrido J.L., Godoy J.A., Olivares G., Reyes A.E., Alvarez A., Bronfman M., Inestrosa N.C. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Molecular Psychiatry 2003, 8:195-208.
51. De Ferrari G.V., Moon R.T. The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 2006, 25:7545-7553.
52. De Ferrari G.V., Papassotiropoulos A., Biechele T., Wavrant De-Vrieze F., Avila M.E., Major M.B., Myers A., Saez K., Henriquez J.P., Zhao A., et al. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:9434-9439.
53. Driver J.E., Racca C., Cunningham M.O., Towers S.K., Davies C.H., Whittington M.A., LeBeau F.E. Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP). European Journal of Neuroscience 2007, 26:1280-1288.
54. Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends in Neurosciences 2012, 35:47-56.
55. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nature Genetics 2004, 36:131-137.
56. Engel T., Goni-Oliver P., Lucas J.J., Avila J., Hernandez F. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Journal of Neurochemistry 2006, 99:1445-1455.
57. Engel T., Hernandez F., Avila J., Lucas J.J. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. Journal of Neuroscience 2006, 26:5083-5090.
58. Farias G.G., Alfaro I.E., Cerpa W., Grabowski C.P., Godoy J.A., Bonansco C., Inestrosa N.C. Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. Journal of Biological Chemistry 2009, 284:15857-15866.
59. Farias G.G., Valles A.S., Colombres M., Godoy J.A., Toledo E.M., Lukas R.J., Barrantes F.J., Inestrosa N.C. Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. Journal of Neuroscience 2007, 27:5313-5325.
60. Feller M.B., Wellis D.P., Stellwagen D., Werblin F.S., Shatz C.J. Requirement for cholinergic synaptic transmission in the propagation of spontaneous retinal waves. Science 1996, 272:1182-1187.
61. Finch P.W., He X., Kelley M.J., Uren A., Schaudies R.P., Popescu N.C., Rudikoff S., Aaronson S.A., Varmus H.E., Rubin J.S. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6770-6775.
62. Foster T.C., McNaughton B.L. Long-term enhancement of CA1 synaptic transmission is due to increased quantal size, not quantal content. Hippocampus 1991, 1:79-91.
63. Ftouh S., Akbar M.T., Hirsch S.R., de Belleroche J.S. Down-regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects. Journal of Neurochemistry 2005, 94:520-530.
64. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., Carlson E., Sagi S.A., Chevallier N., Jin K., et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7130-7135.
65. Gao C., Chen Y.G. Dishevelled: the hub of Wnt signaling. Cellular Signalling 2010, 22:717-727.
66. Garaschuk O., Hanse E., Konnerth A. Developmental profile and synaptic origin of early network oscillations in the CA1 region of rat neonatal hippocampus. Journal of Physiology 1998, 507(Pt 1):219-236.
67. Garrido J.L., Godoy J.A., Alvarez A., Bronfman M., Inestrosa N.C. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB Journal 2002, 16:1982-1984.
68. Gogolla N., Galimberti I., Deguchi Y., Caroni P. Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 2009, 62:510-525.
69. Gordon M.D., Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. Journal of Biological Chemistry 2006, 281:22429-22433.
70. Gotz J., Streffer J.R., David D., Schild A., Hoerndli F., Pennanen L., Kurosinski P., Chen F. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Molecular Psychiatry 2004, 9:664-683.
71. Gould T.D., Manji H.K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 2002, 8:497-511.
72. Green J.L., Kuntz S.G., Sternberg P.W. Ror receptor tyrosine kinases: orphans no more. Trends in Cell Biology 2008, 18:536-544.
73. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Progress in Neurobiology 2001, 65:391-426.
74. Grumolato L., Liu G., Mong P., Mudbhary R., Biswas R., Arroyave R., Vijayakumar S., Economides A.N., Aaronson S.A. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes & Development 2010, 24:2517-2530.
75. Guo W., Murthy A.C., Zhang L., Johnson E.B., Schaller E.G., Allan A.M., Zhao X. Inhibition of GSK3beta improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Human Molecular Genetics 2012, 21:681-691.
76. Hall A.C., Lucas F.R., Salinas P.C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 2000, 100:525-535.
77. Han C., Lin X. Shifted from Wnt to Hedgehog signaling pathways. Molecular Cell 2005, 17:321-322.
78. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009, 41:1088-1093.
79. Henriquez J.P., Webb A., Bence M., Bildsoe H., Sahores M., Hughes S.M., Salinas P.C. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18812-18817.
80. Hermann D., Both M., Ebert U., Gross G., Schoemaker H., Draguhn A., Wicke K., Nimmrich V. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes. Neuroscience 2009, 162:1081-1090.
81. Hernandez F., Borrell J., Guaza C., Avila J., Lucas J.J. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. Journal of Neurochemistry 2002, 83:1529-1533.
82. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., Chesselet M.F. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
83. Hodar C., Assar R., Colombres M., Aravena A., Pavez L., Gonzalez M., Martinez S., Inestrosa N.C., Maass A. Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method. BMC Genomics 2010, 11:348.
84. Hooper C., Killick R., Lovestone S. The GSK3 hypothesis of Alzheimer's disease. Journal of Neurochemistry 2008, 104:1433-1439.
85. Hooper C., Markevich V., Plattner F., Killick R., Schofield E., Engel T., Hernandez F., Anderton B., Rosenblum K., Bliss T., et al. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. European Journal of Neuroscience 2007, 25:81-86.
86. Inestrosa N., De Ferrari G.V., Garrido J.L., Alvarez A., Olivares G.H., Barria M.I., Bronfman M., Chacon M.A. Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochemistry International 2002, 41:341-344.
87. Inestrosa N.C., Arenas E. Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience 2010, 11:77-86.
88. Inestrosa N.C., Montecinos-Oliva C., Fuenzalida M. Wnt signaling: role in Alzheimer disease and schizophrenia. Journal of Neuroimmune Pharmacology 2012, 7:788-807.
89. Jope R.S., Bijur G.N. Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Molecular Psychiatry 2002, 7(Suppl. 1):S35-S45.
90. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004, 29:95-102.
91. Kaladchibachi S.A., Doble B., Anthopoulos N., Woodgett J.R., Manoukian A.S. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. Journal of Circadian Rhythms 2007, 5:3.
92. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37:925-937.
93. Killick R., Ribe E.M., Al-Shawi R., Malik B., Hooper C., Fernandes C., Dobson R., Nolan P.M., Lourdusamy A., Furney S., et al. Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Molecular Psychiatry 2012, 1-11.
94. Kishida S., Hamao K., Inoue M., Hasegawa M., Matsuura Y., Mikoshiba K., Fukuda M., Kikuchi A. Dvl regulates endo- and exocytotic processes through binding to synaptotagmin. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 2007, 12:49-61.
95. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:8455-8459.
96. Kohn A.D., Moon R.T. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005, 38:439-446.
97. 2+ fluctuations. Journal of Neurobiology 1998, 37:110-130.
98. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009, 41:1094-1099.
99. Larner A.J., Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. Journal of Neurology 2006, 253:139-158.
100. Larson J., Wong D., Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Research 1986, 368:347-350.
101. Li G., Pleasure S.J. Morphogenesis of the dentate gyrus: what we are learning from mouse mutants. Developmental Neuroscience 2005, 27:93-99.
102. Li H.L., Wang H.H., Liu S.J., Deng Y.Q., Zhang Y.J., Tian Q., Wang X.C., Chen X.Q., Yang Y., Zhang J.Y., et al. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:3591-3596.
103. Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., Jope R.S. In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004, 29:1426-1431.
104. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
105. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004, 20:781-810.
106. Lu B. BDNF and activity-dependent synaptic modulation. Learning & Memory 2003, 10:86-98.
107. Lu W., Yamamoto V., Ortega B., Baltimore D. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 2004, 119:97-108.
108. Lucas F.R., Salinas P.C. WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Developmental Biology 1997, 192:31-44.
109. Lucas J.J., Hernandez F., Gomez-Ramos P., Moran M.A., Hen R., Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO Journal 2001, 20:27-39.
110. Lucki I., Dalvi A., Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berlin) 2001, 155:315-322.
111. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell 2009, 17:9-26.
112. Maguschak K.A., Ressler K.J. Beta-catenin is required for memory consolidation. Nature Neuroscience 2008, 11:1319-1326.
113. Majewska A., Brown E., Ross J., Yuste R. Mechanisms of calcium decay kinetics in hippocampal spines: role of spine calcium pumps and calcium diffusion through the spine neck in biochemical compartmentalization. Journal of Neuroscience 2000, 20:1722-1734.
114. Majewska A., Tashiro A., Yuste R. Regulation of spine calcium dynamics by rapid spine motility. Journal of Neuroscience 2000, 20:8262-8268.
115. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325.
116. Marques G. Morphogens and synaptogenesis in Drosophila. Journal of Neurobiology 2005, 64:417-434.
117. Masland R.H. Maturation of function in the developing rabbit retina. Journal of Comparative Neurology 1977, 175:275-286.
118. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
119. Maya Vetencourt J.F., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castren E., Maffei L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320:385-388.
120. Mayeux R., Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine 2012, 2:1-18.
121. McMahon A.P., Moon R.T. Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 1989, 58:1075-1084.
122. McMahon A.P., Moon R.T. int-1 - a proto-oncogene involved in cell signalling. Development 1989, 107(Suppl):161-167.
123. Menendez M. Down syndrome, Alzheimer's disease and seizures. Brain and Development 2005, 27:246-252.
124. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biology 2006, 4:e115.
125. Mikels A.J., Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006, 25:7461-7468.
126. Mire E., Mezzera C., Leyva-Diaz E., Paternain A.V., Squarzoni P., Bluy L., Castillo-Paterna M., Lopez M.J., Peregrin S., Tessier-Lavigne M., et al. Spontaneous activity regulates Robo1 transcription to mediate a switch in thalamocortical axon growth. Nature Neuroscience 2012, 15:1134-1143.
127. Miyaoka T., Seno H., Ishino H. Increased expression of Wnt-1 in schizophrenic brains. Schizophrenia Research 1999, 38:1-6.
128. Montcouquiol M., Crenshaw E.B., Kelley M.W. Noncanonical Wnt signaling and neural polarity. Annual Review of Neuroscience 2006, 29:363-386.
129. Moody W.J., Bosma M.M. Ion channel development, spontaneous activity, and activity-dependent development in nerve and muscle cells. Physiological Reviews 2005, 85:883-941.
130. Moon R.T., Kohn A.D., De Ferrari G.V., Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nature Reviews Genetics 2004, 5:691-701.
131. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:6990-6995.
132. Nusse R., Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO Journal 2012, 31:2670-2684.
133. Nusse R., Varmus H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31:99-109.
134. Oishi I., Suzuki H., Onishi N., Takada R., Kani S., Ohkawara B., Koshida I., Suzuki K., Yamada G., Schwabe G.C., et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes to Cells 2003, 8:645-654.
135. Palop J.J., Chin J., Bien-Ly N., Massaro C., Yeung B.Z., Yu G.Q., Mucke L. Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice. Journal of Neuroscience 2005, 25:9686-9693.
136. Palop J.J., Chin J., Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
137. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
138. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q., Raber J., Masliah E., Mucke L. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9572-9577.
139. Palop J.J., Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Archives of Neurology 2009, 66:435-440.
140. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nature Neuroscience 2010, 13:812-818.
141. Palop J.J., Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?. Neuromolecular Medicine 2010, 12:48-55.
142. Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
143. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. Journal of Neuroscience 2006, 26:9022-9029.
144. Purro S.A., Dickins E.M., Salinas P.C. The secreted Wnt antagonist Dickkopf-1 is required for amyloid beta-mediated synaptic loss. Journal of Neuroscience 2012, 32:3492-3498.
145. Quintanilla R.A., Munoz F.J., Metcalfe M.J., Hitschfeld M., Olivares G., Godoy J.A., Inestrosa N.C. Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. Journal of Biological Chemistry 2005, 280:11615-11625.
146. Rabinowicz A.L., Starkstein S.E., Leiguarda R.C., Coleman A.E. Transient epileptic amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering. Alzheimer Disease and Associated Disorders 2000, 14:231-233.
147. Rattner A., Hsieh J.C., Smallwood P.M., Gilbert D.J., Copeland N.G., Jenkins N.A., Nathans J. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2859-2863.
148. Redmond L., Kashani A.H., Ghosh A. Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron 2002, 34:999-1010.
149. Rijsewijk F., Schuermann M., Wagenaar E., Parren P., Weigel D., Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987, 50:649-657.
150. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J.B., Crews L., Masliah E. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Journal of Neuroscience 2007, 27:1981-1991.
151. Roh M.S., Seo M.S., Kim Y., Kim S.H., Jeon W.J., Ahn Y.M., Kang U.G., Juhnn Y.S., Kim Y.S. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Experimental and Molecular Medicine 2007, 39:353-360.
152. Rosso S.B., Sussman D., Wynshaw-Boris A., Salinas P.C. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nature Neuroscience 2005, 8:34-42.
153. Rulifson E.J., Wu C.H., Nusse R. Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Molecular Cell 2000, 6:117-126.
154. Ryan K.A., Pimplikar S.W. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. Journal of Cell Biology 2005, 171:327-335.
155. Ryan T.A., Reuter H., Wendland B., Schweizer F.E., Tsien R.W., Smith S.J. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 1993, 11:713-724.
156. Ryder J., Su Y., Liu F., Li B., Zhou Y., Ni B. Divergent roles of GSK3 and CDK5 in APP processing. Biochemical and Biophysical Research Communications 2003, 312:922-929.
157. Safholm A., Leandersson K., Dejmek J., Nielsen C.K., Villoutreix B.O., Andersson T. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. The Journal of Biological Chemistry 2006, 281:2740-2749.
158. Safholm A., Tuomela J., Rosenkvist J., Dejmek J., Harkonen P., Andersson T. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2008, 14:6556-6563.
159. Saganich M.J., Schroeder B.E., Galvan V., Bredesen D.E., Koo E.H., Heinemann S.F. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. Journal of Neuroscience 2006, 26:13428-13436.
160. Schwarz-Romond T., Fiedler M., Shibata N., Butler P.J., Kikuchi A., Higuchi Y., Bienz M. The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nature Structural & Molecular Biology 2007, 14:484-492.
161. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. Journal of Alzheimer's Disease: JAD 2001, 3:75-80.
162. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. Journal of Neuroscience 2007, 27:2866-2875.
163. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008, 14:837-842.
164. Shimizu H., Julius M.A., Giarre M., Zheng Z., Brown A.M., Kitajewski J. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth & Differentiation 1997, 8:1349-1358.
165. Shimogori T., VanSant J., Paik E., Grove E.A. Members of the Wnt, Fz, and Frp gene families expressed in postnatal mouse cerebral cortex. Journal of Comparative Neurology 2004, 473:496-510.
166. Sjostrom P.J., Rancz E.A., Roth A., Hausser M. Dendritic excitability and synaptic plasticity. Physiological Reviews 2008, 88:769-840.
167. Slusarski D.C., Corces V.G., Moon R.T. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 1997, 390:410-413.
168. Slusarski D.C., Yang-Snyder J., Busa W.B., Moon R.T. Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. Developmental Biology 1997, 182:114-120.
169. Speese S.D., Budnik V. Wnts: up-and-coming at the synapse. Trends in Neurosciences 2007, 30:268-275.
170. Stranahan A.M., Lee K., Becker K.G., Zhang Y., Maudsley S., Martin B., Cutler R.G., Mattson M.P. Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiology of Aging 2010, 31:1937-1949.
171. Sutton L.P., Honardoust D., Mouyal J., Rajakumar N., Rushlow W.J. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3. Journal of Neurochemistry 2007, 102:153-169.
172. Tabatadze N., Tomas C., McGonigal R., Lin B., Schook A., Routtenberg A. Wnt transmembrane signaling and long-term spatial memory. Hippocampus 2012, 22:1228-1241.
173. Tahvildari B., Wolfel M., Duque A., McCormick D.A. Selective functional interactions between excitatory and inhibitory cortical neurons and differential contribution to persistent activity of the slow oscillation. Journal of Neuroscience 2012, 32:12165-12179.
174. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9637-9641.
175. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neuroscience Letters 1996, 203:33-36.
176. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:7789-7793.
177. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J.P., He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407:530-535.
178. Tilleman K., Stevens I., Spittaels K., Haute C.V., Clerens S., Van Den Bergh G., Geerts H., Van Leuven F., Vandesande F., Moens L. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2002, 2:94-104.
179. Toledo E.M., Colombres M., Inestrosa N.C. Wnt signaling in neuroprotection and stem cell differentiation. Progress in Neurobiology 2008, 86:281-296.
180. Toledo E.M., Inestrosa N.C. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Molecular Psychiatry 2010, 15:272-285. (228).
181. van Amerongen R., Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136:3205-3214.
182. Varela-Nallar L., Alfaro I.E., Serrano F.G., Parodi J., Inestrosa N.C. Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21164-21169.
183. Varela-Nallar L., Grabowski C.P., Alfaro I.E., Alvarez A.R., Inestrosa N.C. Role of the Wnt receptor Frizzled-1 in presynaptic differentiation and function. Neural Development 2009, 4:41.
184. Varela-Nallar L., Ramirez V.T., Gonzalez-Billault C., Inestrosa N.C. Frizzled receptors in neurons: from growth cones to the synapse. Cytoskeleton (Hoboken) 2012, 69:528-534.
185. Veeman M.T., Axelrod J.D., Moon R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Developmental Cell 2003, 5:367-377.
186. Villette V., Poindessous-Jazat F., Simon A., Lena C., Roullot E., Bellessort B., Epelbaum J., Dutar P., Stephan A. Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-beta pathology in the rat. Journal of Neuroscience 2010, 30:10991-11003.
187. Vogt D.L., Thomas D., Galvan V., Bredesen D.E., Lamb B.T., Pimplikar S.W. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiology of Aging 2011, 32:1725-1729.
188. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
189. Walsh D.M., Townsend M., Podlisny M.B., Shankar G.M., Fadeeva J.V., El Agnaf O., Hartley D.M., Selkoe D.J. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:2455-2462.
190. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Research 2002, 924:133-140.
191. Wang J., Ruan N.J., Qian L., Lei W.L., Chen F., Luo Z.G. Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. Journal of Biological Chemistry 2008, 283:21668-21675.
192. Wang J., Shou J., Chen X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 2000, 19:1843-1848.
193. Wayman G.A., Impey S., Marks D., Saneyoshi T., Grant W.F., Derkach V., Soderling T.R. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 2006, 50:897-909.
194. Wehrli M., Dougan S.T., Caldwell K., O'Keefe L., Schwartz S., Vaizel-Ohayon D., Schejter E., Tomlinson A., DiNardo S. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 2000, 407:527-530.
195. Weisstaub N.V., Zhou M., Lira A., Lambe E., Gonzalez-Maeso J., Hornung J.P., Sibille E., Underwood M., Itohara S., Dauer W.T., et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313:536-540.
196. Wong G.T., Gavin B.J., McMahon A.P. Differential transformation of mammary epithelial cells by Wnt genes. Molecular and Cellular Biology 1994, 14:6278-6286.
197. Yamanaka H., Moriguchi T., Masuyama N., Kusakabe M., Hanafusa H., Takada R., Takada S., Nishida E. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Reports 2002, 3:69-75.
198. Yang J., Si T., Ling Y., Ruan Y., Han Y., Wang X., Zhang H., Kong Q., Li X., Liu C., et al. Association study of the human FZD3 locus with schizophrenia. Biological Psychiatry 2003, 54:1298-1301.
199. Yu X., Malenka R.C. Beta-catenin is critical for dendritic morphogenesis. Nature Neuroscience 2003, 6:1169-1177.
200. Yuste R., Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annual Review of Neuroscience 2001, 24:1071-1089.
201. Yuste R., Majewska A., Holthoff K. From form to function: calcium compartmentalization in dendritic spines. Nature Neuroscience 2000, 3:653-659.
202. Yuste R., Peinado A., Katz L.C. Neuronal domains in developing neocortex. Science 1992, 257:665-669.
203. Zhang Y., McLaughlin R., Goodyer C., LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. Journal of Cell Biology 2002, 156:519-529.
204. Zhang Z., Hartmann H., Do V.M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Sommer B., van de Wetering M., Clevers H., Saftig P., et al. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 1998, 395:698-702.